References: |
Ringel, I., et al.: J. Natl. Cancer Inst., 83, 288 (1991), Extra, J.-M., et al.: Cancer Res., 53, 1037 (1993). Pienta, K.J. "Preclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancer." Semin Oncol. 4: 3-7 (2001). Yoshida, K., et al. "Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer." Anticancer Res. 24: 1843-1851 (2004). Tabernero, J., et al. "A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer." Ann Oncol. 15: 1358-1365 (2004). |